PortfoliosLab logoPortfoliosLab logo
ARQT vs. SHOP
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

ARQT vs. SHOP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arcutis Biotherapeutics, Inc. (ARQT) and Shopify Inc. (SHOP). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

ARQT vs. SHOP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
ARQT
Arcutis Biotherapeutics, Inc.
-18.87%108.47%331.27%-78.18%-28.64%-26.27%29.04%
SHOP
Shopify Inc.
-26.31%51.39%36.50%124.43%-74.80%21.68%143.09%

Fundamentals

EPS

ARQT:

-$0.12

SHOP:

$1.41

PS Ratio

ARQT:

8.26

SHOP:

13.15

Total Revenue (TTM)

ARQT:

$376.07M

SHOP:

$7.88B

Gross Profit (TTM)

ARQT:

$339.38M

SHOP:

$5.56B

EBITDA (TTM)

ARQT:

-$1.11M

SHOP:

$1.61B

Returns By Period

In the year-to-date period, ARQT achieves a -18.87% return, which is significantly higher than SHOP's -26.31% return.


ARQT

1D
10.45%
1M
-12.64%
YTD
-18.87%
6M
24.99%
1Y
50.64%
3Y*
28.90%
5Y*
-4.55%
10Y*

SHOP

1D
6.13%
1M
-1.75%
YTD
-26.31%
6M
-20.18%
1Y
24.24%
3Y*
35.25%
5Y*
0.53%
10Y*
45.21%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ARQT vs. SHOP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARQT
ARQT Risk / Return Rank: 7171
Overall Rank
ARQT Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
ARQT Sortino Ratio Rank: 7272
Sortino Ratio Rank
ARQT Omega Ratio Rank: 6767
Omega Ratio Rank
ARQT Calmar Ratio Rank: 7373
Calmar Ratio Rank
ARQT Martin Ratio Rank: 7171
Martin Ratio Rank

SHOP
SHOP Risk / Return Rank: 5757
Overall Rank
SHOP Sharpe Ratio Rank: 5757
Sharpe Ratio Rank
SHOP Sortino Ratio Rank: 5757
Sortino Ratio Rank
SHOP Omega Ratio Rank: 5656
Omega Ratio Rank
SHOP Calmar Ratio Rank: 5656
Calmar Ratio Rank
SHOP Martin Ratio Rank: 5858
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARQT vs. SHOP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Arcutis Biotherapeutics, Inc. (ARQT) and Shopify Inc. (SHOP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ARQTSHOPDifference

Sharpe ratio

Return per unit of total volatility

0.85

0.40

+0.45

Sortino ratio

Return per unit of downside risk

1.65

1.01

+0.64

Omega ratio

Gain probability vs. loss probability

1.19

1.13

+0.06

Calmar ratio

Return relative to maximum drawdown

1.56

0.59

+0.96

Martin ratio

Return relative to average drawdown

3.67

1.44

+2.23

ARQT vs. SHOP - Sharpe Ratio Comparison

The current ARQT Sharpe Ratio is 0.85, which is higher than the SHOP Sharpe Ratio of 0.40. The chart below compares the historical Sharpe Ratios of ARQT and SHOP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


ARQTSHOPDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.85

0.40

+0.45

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.06

0.01

-0.07

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.77

Sharpe Ratio (All Time)

Calculated using the full available price history

0.02

0.72

-0.70

Correlation

The correlation between ARQT and SHOP is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

ARQT vs. SHOP - Dividend Comparison

Neither ARQT nor SHOP has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ARQT vs. SHOP - Drawdown Comparison

The maximum ARQT drawdown since its inception was -95.02%, which is greater than SHOP's maximum drawdown of -84.82%. Use the drawdown chart below to compare losses from any high point for ARQT and SHOP.


Loading graphics...

Drawdown Indicators


ARQTSHOPDifference

Max Drawdown

Largest peak-to-trough decline

-95.02%

-84.82%

-10.20%

Max Drawdown (1Y)

Largest decline over 1 year

-31.99%

-38.18%

+6.19%

Max Drawdown (5Y)

Largest decline over 5 years

-94.71%

-84.82%

-9.89%

Max Drawdown (10Y)

Largest decline over 10 years

-84.82%

Current Drawdown

Current decline from peak

-36.29%

-33.74%

-2.55%

Average Drawdown

Average peak-to-trough decline

-50.47%

-28.09%

-22.38%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.56%

15.78%

-2.22%

Volatility

ARQT vs. SHOP - Volatility Comparison

Arcutis Biotherapeutics, Inc. (ARQT) and Shopify Inc. (SHOP) have volatilities of 15.89% and 15.49%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ARQTSHOPDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.89%

15.49%

+0.40%

Volatility (6M)

Calculated over the trailing 6-month period

43.77%

38.93%

+4.84%

Volatility (1Y)

Calculated over the trailing 1-year period

60.13%

60.86%

-0.73%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

71.95%

65.06%

+6.89%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

77.55%

58.59%

+18.96%

Financials

ARQT vs. SHOP - Financials Comparison

This section allows you to compare key financial metrics between Arcutis Biotherapeutics, Inc. and Shopify Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B2.50B3.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
129.50M
0
(ARQT) Total Revenue
(SHOP) Total Revenue
Values in USD except per share items